32 results
Who to test for BRCA 1/2?
Female Breast Cancer:
 • ≤ 45-50 years at diagnosis
 • Triple
Female Breast Cancer ... with breast cancer ... in this table ... factors in this table ... #indications #oncology
Most Common Breast Masses - Comparison between Fibroadenoma, Cysts and Cancer

#Diagnosis #Oncology #Breast #Masses #Comparison #Table
Most Common Breast ... Fibroadenoma, Cysts and Cancer ... #Diagnosis #Oncology ... #Breast #Masses ... #Comparison #Table
Treatment of breast cancer: a simplified view
surgical therapy - 5-7 weeks
 - lumpectomy +
 - radiation
Treatment of breast ... cancer: a simplified ... chemotherapy - 12 ... #cancer #treatment ... timeline #simplified #oncology
Early Breast Cancer - Management Algorithm
 • Luminal A-like (ER+ and/or PR+, HER2- and low proliferation)
Early Breast Cancer ... 0111-2 #Early #Breast ... #Cancer #Management ... #Algorithm #treatment ... #oncology
Causes of Localized Lymphadenopathy - Differential Diagnosis Algorithm
Cervical:
 - Anterior
     • Infection
Thoracic Malignancy (Breast ... Thoracic Wall, Breast ... ) • Cancer (In ... Infection • Cancer ... #Oncology
Five Year Cancer survival rates in the USA

Despite increasing global cancer deaths, cancer death rates across
Five Year Cancer ... , and improved treatment ... who survive at least ... detection and improved treatment ... #Epidemiology #Oncology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
incidental DVT or PE in cancer ... thrombosis in cancer ... lead-in of at least ... Anticoagulation #Management #Hematology ... #Oncology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
algorithm for the treatment ... of cancer-associated ... VTE #Malignancy #Cancer ... Anticoagulation #Management #Hematology ... #Oncology
ED Treatment of 
Abnormal Uterine Bleeding 

Hemodynamically unstable 
Resuscitation 
 • ABCs! 
 • Fluids +
ED Treatment of ... Hemodynamically stable ... thromboembolic disease, breast ... endometrial path0100' or breast ... cancer IM progestin
(DOAC interactions) Cancer-treatment specific inducers (↑) and inhibitors (↓)
of cytochrome p450 CYP3A4 and P-glycoprotein.

DOACs are substrates
interactions) Cancer-treatment ... #Chemotherapy #Oncology ... #Hematology #Interactions ... #Table #Pharmacology